Source:http://linkedlifedata.com/resource/pubmed/id/12791659
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2003-9-8
|
pubmed:abstractText |
We have previously found that P210BCR-ABL increases the adhesion of hematopoietic cell lines to fibronectin by a mechanism that is independent of tyrosine kinase activity. To investigate the pathway(s) by which P210BCR-ABL influences cell adhesion, we used a quantitative cell adhesion device that can discern small changes in cell adhesion to assay P210BCR-ABL with mutations in several critical domains. We expressed P210BCR-ABL mutants in 32D myeloblast cells and found that binding to fibronectin is mediated primarily by the alpha5beta1 integrin. We performed a structure/function analysis to map domains important for cell adhesion. Increased adhesion was mediated by 3 domains: (1) the N-terminal coiled-coil domain that facilitates oligomerization and F-actin localization; (2) bcr sequences between aa 163 to 210; and (3) F-actin localization through the C-terminal actin-binding domain of c-abl. We compared our adhesion results with the ability of these mutants to cause a chronic myelogenous leukemia (CML)-like disease in a murine bone marrow transplantation assay and found that adhesion to fibronectin did not correlate with the ability of these mutants to cause CML. Together, our results suggest that F-actin localization may play a pivotal role in modulating adhesion but that it is dispensable for the development of CML.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Actins,
http://linkedlifedata.com/resource/pubmed/chemical/Fibronectins,
http://linkedlifedata.com/resource/pubmed/chemical/Fusion Proteins, bcr-abl,
http://linkedlifedata.com/resource/pubmed/chemical/Integrin alpha4beta1,
http://linkedlifedata.com/resource/pubmed/chemical/Integrin alpha5beta1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
102
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2220-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12791659-Actins,
pubmed-meshheading:12791659-Animals,
pubmed-meshheading:12791659-Bone Marrow Cells,
pubmed-meshheading:12791659-Bone Marrow Transplantation,
pubmed-meshheading:12791659-Cell Adhesion,
pubmed-meshheading:12791659-Fibronectins,
pubmed-meshheading:12791659-Fusion Proteins, bcr-abl,
pubmed-meshheading:12791659-Integrin alpha4beta1,
pubmed-meshheading:12791659-Integrin alpha5beta1,
pubmed-meshheading:12791659-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:12791659-Mice,
pubmed-meshheading:12791659-Mice, Inbred C57BL,
pubmed-meshheading:12791659-Protein Binding,
pubmed-meshheading:12791659-Protein Structure, Tertiary
|
pubmed:year |
2003
|
pubmed:articleTitle |
Localization of BCR-ABL to F-actin regulates cell adhesion but does not attenuate CML development.
|
pubmed:affiliation |
Department of Pathology and Laboratory Medicine, University of Pennsylvania, 611 BRB II/III, 421 Curie Blvd, Philadelphia, PA 19104-6160.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|